About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 110 record(s)
Req # A-2022-000705
Adverse Drug Reaction (ADR) for VEKLURY. Report number: 000995168.Organization: Health Canada
September 2022
Req # A-2022-000709
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: MIN-287192.Organization: Health Canada
September 2022
Req # A-2022-000711
Adverse Drug Reactions (ADRs) for GAMMAGARD LIQUID. Report numbers: 966356, 944908, 990508, 952532, 979966, 968573, 951018, 992976, 990937, 994605.Organization: Health Canada
September 2022
Req # A-2022-000717
Adverse Drug Reaction (ADR). Report number: 000996710.Organization: Health Canada
September 2022
Req # A-2022-000739
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108516-175.Organization: Health Canada
September 2022
Req # A-2022-000742
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108585-282, Membership to the Clinical Laboratory Standards Institute in 2023-24.Organization: Health Canada
September 2022
Req # A-2022-000747
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108545-748, Upcoming Publication of Proposed and Final Post-Market Decisions for Pesticides.Organization: Health Canada
September 2022
Req # A-2016-000415
The reviewer’s comments and correspondence pertaining to the safety, efficacy, labelling and specifically the approval for Gynecare Prolift +M Pelvic Floor Repair Systems approved for use in Canada on September 8, 2008 on the transvaginal mesh products manufactured by Johnson & Johnson.Organization: Health Canada
September 2022
Req # A-2017-000743
All records regarding retention periods for records held by the Healthy Environment and Safety Branch (HECSB), the Communications and Public Affairs Branch (CPAB) and the Corporate Services Branch (CSB) from November 11, 2011 to August 28, 2017.Organization: Health Canada
September 2022
Req # A-2018-001677
The information that supported registration of the following natural product: Riva Star (Kit) (Natural Product Number (NPN): 80085846). The documents Health Canada relied upon to determine the efficacy and safety of these products and those that support the recommended uses or purposes as presented in the product information available in the Licensed Natural Health Products Database.Organization: Health Canada
September 2022